DK1664770T3 - Fremgangsmåde til bestemmelse af indvirkningen af en multikomponent-syntetisk-produkt-blanding på den biologiske profil for sygdom inden for en gruppe af levende systemer og udviklingen af nye kombinatoriske interventioner - Google Patents
Fremgangsmåde til bestemmelse af indvirkningen af en multikomponent-syntetisk-produkt-blanding på den biologiske profil for sygdom inden for en gruppe af levende systemer og udviklingen af nye kombinatoriske interventionerInfo
- Publication number
- DK1664770T3 DK1664770T3 DK04774923T DK04774923T DK1664770T3 DK 1664770 T3 DK1664770 T3 DK 1664770T3 DK 04774923 T DK04774923 T DK 04774923T DK 04774923 T DK04774923 T DK 04774923T DK 1664770 T3 DK1664770 T3 DK 1664770T3
- Authority
- DK
- Denmark
- Prior art keywords
- disease
- biological profile
- impact
- determining
- group
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/60—ICT specially adapted for the handling or processing of medical references relating to pathologies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2550/00—Electrophoretic profiling, e.g. for proteome analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Theoretical Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Evolutionary Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03077804A EP1512970A1 (en) | 2003-09-05 | 2003-09-05 | Method for determining the impact of a multicomponent mixture on the biological profile of a disease |
| PCT/NL2004/000617 WO2005024421A1 (en) | 2003-09-05 | 2004-09-03 | Method for determining the impact of a multicomponent synthetic product mixture on the biological profile of a disease within a group of living systems and the development of new combinatorial interventions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1664770T3 true DK1664770T3 (da) | 2008-03-25 |
Family
ID=34130247
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04774923T DK1664770T3 (da) | 2003-09-05 | 2004-09-03 | Fremgangsmåde til bestemmelse af indvirkningen af en multikomponent-syntetisk-produkt-blanding på den biologiske profil for sygdom inden for en gruppe af levende systemer og udviklingen af nye kombinatoriske interventioner |
| DK04774922T DK1664767T3 (da) | 2003-09-05 | 2004-09-03 | Fremgangsmåde til bestemmelse af indvirkningen af en af flere komponenter bestående naturproduktblanding på den biologiske profil for en sygdom inden for en gruppe af levende systemer og udvikling og kvalitetskontrol af medicin baseret på naturprodukter |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04774922T DK1664767T3 (da) | 2003-09-05 | 2004-09-03 | Fremgangsmåde til bestemmelse af indvirkningen af en af flere komponenter bestående naturproduktblanding på den biologiske profil for en sygdom inden for en gruppe af levende systemer og udvikling og kvalitetskontrol af medicin baseret på naturprodukter |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20070020180A1 (da) |
| EP (3) | EP1512970A1 (da) |
| JP (2) | JP4675896B2 (da) |
| CN (2) | CN1875273A (da) |
| AT (2) | ATE378593T1 (da) |
| DE (2) | DE602004010155T2 (da) |
| DK (2) | DK1664770T3 (da) |
| EA (1) | EA011959B1 (da) |
| ES (2) | ES2297475T3 (da) |
| WO (2) | WO2005024420A1 (da) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7425700B2 (en) | 2003-05-22 | 2008-09-16 | Stults John T | Systems and methods for discovery and analysis of markers |
| EP1512970A1 (en) * | 2003-09-05 | 2005-03-09 | Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO | Method for determining the impact of a multicomponent mixture on the biological profile of a disease |
| US7729789B2 (en) * | 2004-05-04 | 2010-06-01 | Fisher-Rosemount Systems, Inc. | Process plant monitoring based on multivariate statistical analysis and on-line process simulation |
| US20080183101A1 (en) * | 2006-08-17 | 2008-07-31 | Jonathan Richard Stonehouse | Salivary analysis |
| JP5491377B2 (ja) * | 2007-03-30 | 2014-05-14 | ９８９８リミテッド | 天然物開発のための薬剤プラットフォーム技術 |
| DE102008011013B4 (de) * | 2008-02-25 | 2014-11-13 | Mevitec Gmbh | Verfahren und Einrichtung zur komplexen Stoffwechselanalyse |
| KR101144237B1 (ko) * | 2009-12-29 | 2012-05-11 | 한국기초과학지원연구원 | 고분해능 질량분석법과 약리활성검사를 이용한 천연물의 약리 활성물질 발굴 방법 |
| SG193006A1 (en) * | 2011-03-02 | 2013-10-30 | Berg Llc | Interrogatory cell-based assays and uses thereof |
| AU2012376214B2 (en) | 2012-04-02 | 2019-02-14 | Berg Llc | Interrogatory cell-based assays and uses thereof |
| JP2014020831A (ja) * | 2012-07-13 | 2014-02-03 | Kyoto Univ | 混合物試料の属性を識別する方法及び装置 |
| EP3017300A4 (en) * | 2013-07-01 | 2017-03-08 | Ixcela, Inc. | Systems biology approach to therapy |
| WO2016039348A1 (ja) * | 2014-09-10 | 2016-03-17 | 一般財団法人ニッセンケン品質評価センター | タンパク質繊維の鑑別方法 |
| NZ730197A (en) | 2014-09-11 | 2022-07-01 | Berg Llc | Bayesian causal relationship network models for healthcare diagnosis and treatment based on patient data |
| CN109115904B (zh) * | 2018-07-25 | 2021-02-02 | 山西广誉远国药有限公司 | 一种定坤丹uplc指纹图谱的构建方法及其应用 |
| EP4010456A4 (en) | 2019-08-05 | 2023-09-13 | Seer, Inc. | SYSTEMS AND METHODS FOR SAMPLE PREPARATION, DATA GENERATION AND ANALYSIS OF CORONA PROTEIN |
| CN111180007A (zh) * | 2019-12-03 | 2020-05-19 | 深圳市开物成务中医药科技有限公司 | 一种安全、有效、高质量中药开发平台系统及实现方法 |
| CN111060640A (zh) * | 2019-12-27 | 2020-04-24 | 深圳市开物成务中医药科技有限公司 | 测定与胰岛素耐受性相关的血脂谱的方法、应用及装置 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5885782A (en) * | 1994-09-13 | 1999-03-23 | Nce Pharmaceuticals, Inc. | Synthetic antibiotics |
| US5563043A (en) * | 1994-10-24 | 1996-10-08 | Spiral Biotech, Inc. | Method for measuring the bactericidal and bacteriostatic effects of antimicrobial agents |
| US6379714B1 (en) * | 1995-04-14 | 2002-04-30 | Pharmaprint, Inc. | Pharmaceutical grade botanical drugs |
| WO1997020076A1 (en) * | 1995-11-29 | 1997-06-05 | Nexstar Pharmaceuticals, Inc. | Methods for optimizing multicomponent formulations |
| JP3978529B2 (ja) * | 1998-08-03 | 2007-09-19 | 大正製薬株式会社 | 冬虫夏草の判別法 |
| US20030044846A1 (en) * | 2001-04-03 | 2003-03-06 | Gary Eldridge | Screening of chemical compounds purified from biological sources |
| EP1263988A2 (en) * | 2000-03-09 | 2002-12-11 | Yale University | Phytomics: a genomic-based approach to herbal compositions |
| US20020095260A1 (en) * | 2000-11-28 | 2002-07-18 | Surromed, Inc. | Methods for efficiently mining broad data sets for biological markers |
| US8068987B2 (en) * | 2001-08-13 | 2011-11-29 | Bg Medicine, Inc. | Method and system for profiling biological systems |
| TW573125B (en) * | 2001-08-29 | 2004-01-21 | Combinatorx Inc | A screening system for identifying drug-drug interactions and methods of use thereof |
| EP1512970A1 (en) * | 2003-09-05 | 2005-03-09 | Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO | Method for determining the impact of a multicomponent mixture on the biological profile of a disease |
| EP1842065B1 (en) * | 2005-01-28 | 2010-12-01 | Children's Medical Center Corporation | Methods for diagnosis and prognosis of bladder cancer |
-
2003
- 2003-09-05 EP EP03077804A patent/EP1512970A1/en not_active Withdrawn
-
2004
- 2004-09-03 DK DK04774923T patent/DK1664770T3/da active
- 2004-09-03 JP JP2006525291A patent/JP4675896B2/ja not_active Expired - Fee Related
- 2004-09-03 AT AT04774922T patent/ATE378593T1/de active
- 2004-09-03 US US10/570,505 patent/US20070020180A1/en not_active Abandoned
- 2004-09-03 DK DK04774922T patent/DK1664767T3/da active
- 2004-09-03 JP JP2006525292A patent/JP2007508603A/ja active Pending
- 2004-09-03 AT AT04774923T patent/ATE378594T1/de active
- 2004-09-03 WO PCT/NL2004/000616 patent/WO2005024420A1/en active IP Right Grant
- 2004-09-03 WO PCT/NL2004/000617 patent/WO2005024421A1/en active IP Right Grant
- 2004-09-03 DE DE602004010155T patent/DE602004010155T2/de not_active Expired - Lifetime
- 2004-09-03 CN CNA2004800324024A patent/CN1875273A/zh active Pending
- 2004-09-03 EA EA200600539A patent/EA011959B1/ru not_active IP Right Cessation
- 2004-09-03 EP EP04774922A patent/EP1664767B1/en not_active Expired - Lifetime
- 2004-09-03 ES ES04774922T patent/ES2297475T3/es not_active Expired - Lifetime
- 2004-09-03 DE DE602004010154T patent/DE602004010154T2/de not_active Expired - Lifetime
- 2004-09-03 CN CNA2004800325525A patent/CN1875274A/zh active Pending
- 2004-09-03 ES ES04774923T patent/ES2297476T3/es not_active Expired - Lifetime
- 2004-09-03 EP EP04774923A patent/EP1664770B1/en not_active Expired - Lifetime
- 2004-09-03 US US10/571,087 patent/US20070160990A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE602004010154D1 (de) | 2007-12-27 |
| CN1875274A (zh) | 2006-12-06 |
| DE602004010155D1 (de) | 2007-12-27 |
| CN1875273A (zh) | 2006-12-06 |
| WO2005024421A1 (en) | 2005-03-17 |
| ATE378594T1 (de) | 2007-11-15 |
| EA011959B1 (ru) | 2009-06-30 |
| DK1664767T3 (da) | 2008-03-25 |
| ES2297476T3 (es) | 2008-05-01 |
| US20070020180A1 (en) | 2007-01-25 |
| DE602004010155T2 (de) | 2008-09-25 |
| WO2005024420A1 (en) | 2005-03-17 |
| JP4675896B2 (ja) | 2011-04-27 |
| EP1664767B1 (en) | 2007-11-14 |
| EP1664770B1 (en) | 2007-11-14 |
| EP1664767A1 (en) | 2006-06-07 |
| ATE378593T1 (de) | 2007-11-15 |
| JP2007510132A (ja) | 2007-04-19 |
| ES2297475T3 (es) | 2008-05-01 |
| DE602004010154T2 (de) | 2008-09-25 |
| EP1512970A1 (en) | 2005-03-09 |
| EP1664770A1 (en) | 2006-06-07 |
| US20070160990A1 (en) | 2007-07-12 |
| EA200600539A1 (ru) | 2006-08-25 |
| JP2007508603A (ja) | 2007-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1664770T3 (da) | Fremgangsmåde til bestemmelse af indvirkningen af en multikomponent-syntetisk-produkt-blanding på den biologiske profil for sygdom inden for en gruppe af levende systemer og udviklingen af nye kombinatoriske interventioner | |
| CY1111612T1 (el) | Μεθοδος για προβλεψη της αποκρισης σε μια θεραπευτικη αγωγη με εναν αναστολεαδιmερισmου του her | |
| CY1114701T1 (el) | Συνθεσεις και μεθοδοι για αυξηση ασβεστοποιησης οστων | |
| SG156625A1 (en) | Method for measuring resistance or sensitivity to docetaxel | |
| ATE463294T1 (de) | Verfahren zur konzentration und reinigung von biologischen verbindungen | |
| DK1804836T3 (da) | Fremgangsmåder til diagnosticering og behandling af graviditetskomplikationer | |
| BRPI0618391A2 (pt) | método para identificar um nucleotìdeo individual, método para seqüenciar uma seqüência de ácido nucleico alvo, e, kit para seqüenciar um ácido nucleico | |
| DE602006017365D1 (de) | Zusammensetzungen für die identifizierung von adenoviren | |
| ATE419388T1 (de) | Nukleinsäureanreicherung | |
| BR0311823B1 (pt) | mÉtodo de determinaÇço de pelo menos um parÂmetro de formaÇço de interesse. | |
| DE602006021223D1 (de) | Verfahren zur identifizierung von trpv2-modulatoren | |
| EA200901436A1 (ru) | Антигенсвязывающие белки, связывающие par-2 | |
| ATE538809T1 (de) | Verfahren zur auswahl von geeigneten patienten für den wt1-impfstoff | |
| DE602005012405D1 (de) | Verfahren zur chiralen inversion von (s)-(+)- und (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepin-5-carbonsäureamid und optisch angereicherten mischungen davon | |
| DK1604203T3 (da) | Fremgangsmåde til direkte bestemmelse af individuelle methotrexatmeta-bolitter | |
| DK1692181T3 (da) | Leptinantagonist og fremgangsmåde til kvantitativ måling af leptin | |
| DE602005017127D1 (de) | Rung und identifizierung von flüssigkeiten | |
| DE602004009243D1 (de) | Verfahren zur den Stoffwechsel betreffenden Führung von eingeleitetem zellulärem Material | |
| DE602005016650D1 (de) | Methoden und system zur identifikation und charakterisierung von peptiden und ihrer funktionellen beziehung mittels berechnung von korrelation | |
| DK1664793T3 (da) | Neurotoksisk aminosyre eller neurotoksisk derivat deraf forbundet med neurologiske lidelser | |
| WO2004113574A3 (en) | Methods for disease screening | |
| DE50312587D1 (de) | Verfahren zur herstellung von acrysäure und polymerisierbare verbindungen | |
| CY1117709T1 (el) | Αναλυτικη μεθοδος για μορια fab και fab' | |
| DE502006002136D1 (de) | Aminocarbonsäureester mit eo/po/buo-blockpolymerisaten und deren verwendung als emulsionsspalter | |
| DE602007004570D1 (de) | Verwendung von Nogo-C bei der Beurteilung von Herzversagen |